Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lara A Ray

Showing results (41-50 of 281) with videos related to

Pageof 29
Sort By:
Experimental and Clinical Psychopharmacology|March 21, 2012
Understanding naltrexone mechanism of action and pharmacogenetics in Asian Americans via behavioral economics: a preliminary studySpencer Bujarski, James MacKillop, Lara A Ray
Alcoholism, Clinical and Experimental Research|September 6, 2021
Alcohol use disorder severity moderates clinical response to vareniclineSuzanna Donato, ReJoyce Green, Lara A Ray
Alcohol and Alcoholism (Oxford, Oxfordshire)|September 5, 2022
The Brief Alcohol Use Disorder Severity Scale: An Initial Validation EvaluationSuzanna Donato, Steven Nieto, Lara A Ray
Alcohol, Clinical & Experimental Research|January 18, 2024
The future of reward and relief drinking profiles: Considerations for social motives, stability of profiles, and tailored interventionsErica N Grodin, Annabel Kady, Lara A Ray
Experimental and Clinical Psychopharmacology|December 30, 2021
The relationship between drinking and smoking in a clinical trial for smoking cessation and drinking reductionReJoyce Green, Amanda K Montoya, Lara A Ray
Frontiers in Psychiatry|March 23, 2011
The Effects of Naltrexone Among Alcohol Non-Abstainers: Results from the COMBINE StudyLara A Ray, Jennifer L Krull, Lorenzo Leggio
Personalized Medicine|May 24, 2018
Pharmacogenetics of the µ-opioid receptor and the treatment of addictionsLara A Ray, James MacKillop, Kent E Hutchison
CNS & Neurological Disorders Drug Targets|March 6, 2010
Naltrexone for the treatment of alcoholism: clinical findings, mechanisms of action, and pharmacogeneticsLara A Ray, Pauline F Chin, Karen Miotto
The American Journal on Addictions|January 31, 2017
Review: Pharmacogenetics of alcoholism treatment: Implications of ethnic diversityAnita Cservenka, Megan M Yardley, Lara A Ray
Alcohol, Clinical & Experimental Research|March 7, 2023
The vicious cycle between (neuro)inflammation and alcohol use disorder: An opportunity to develop new medications?András H Lékó, Lara A Ray, Lorenzo Leggio
Pageof 29

Showing results (41-50 of 281) with videos related to

Sort By:
Pageof 29
Experimental and Clinical Psychopharmacology|March 21, 2012
Understanding naltrexone mechanism of action and pharmacogenetics in Asian Americans via behavioral economics: a preliminary studySpencer Bujarski, James MacKillop, Lara A Ray
Alcoholism, Clinical and Experimental Research|September 6, 2021
Alcohol use disorder severity moderates clinical response to vareniclineSuzanna Donato, ReJoyce Green, Lara A Ray
Alcohol and Alcoholism (Oxford, Oxfordshire)|September 5, 2022
The Brief Alcohol Use Disorder Severity Scale: An Initial Validation EvaluationSuzanna Donato, Steven Nieto, Lara A Ray
Alcohol, Clinical & Experimental Research|January 18, 2024
The future of reward and relief drinking profiles: Considerations for social motives, stability of profiles, and tailored interventionsErica N Grodin, Annabel Kady, Lara A Ray
Experimental and Clinical Psychopharmacology|December 30, 2021
The relationship between drinking and smoking in a clinical trial for smoking cessation and drinking reductionReJoyce Green, Amanda K Montoya, Lara A Ray
Frontiers in Psychiatry|March 23, 2011
The Effects of Naltrexone Among Alcohol Non-Abstainers: Results from the COMBINE StudyLara A Ray, Jennifer L Krull, Lorenzo Leggio
Personalized Medicine|May 24, 2018
Pharmacogenetics of the µ-opioid receptor and the treatment of addictionsLara A Ray, James MacKillop, Kent E Hutchison
CNS & Neurological Disorders Drug Targets|March 6, 2010
Naltrexone for the treatment of alcoholism: clinical findings, mechanisms of action, and pharmacogeneticsLara A Ray, Pauline F Chin, Karen Miotto
The American Journal on Addictions|January 31, 2017
Review: Pharmacogenetics of alcoholism treatment: Implications of ethnic diversityAnita Cservenka, Megan M Yardley, Lara A Ray
Alcohol, Clinical & Experimental Research|March 7, 2023
The vicious cycle between (neuro)inflammation and alcohol use disorder: An opportunity to develop new medications?András H Lékó, Lara A Ray, Lorenzo Leggio
Pageof 29